Acura Pharmaceuticals Provides Development Update on Its LIMITX(TM) Abuse Deterrent Technology
December 17, 2015 16:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - December 17, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that's it is...
Acura Pharmaceuticals Receives 2015 Frost & Sullivan North American Opioid Oral Abuse Deterrence Technology Innovation Award
November 10, 2015 06:00 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - November 10, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse-deterrent drugs, announced that it received the 2015...
Acura Pharmaceuticals Announces Third Quarter 2015 Financial Results
November 04, 2015 16:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - November 04, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals to Host Third Quarter 2015 Financial Results Conference Call on November 5, 2015
October 28, 2015 06:30 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - October 28, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company...
Acura Receives $2.5 Million Milestone Payment From Egalet Corporation
October 12, 2015 06:30 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - October 12, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), today announced the receipt of a $2.5 million milestone payment from Egalet Corporation (NASDAQ: EGLT)...
Acura Pharmaceuticals Meets NASDAQ's Continuing Listing Requirement
September 16, 2015 16:10 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - September 16, 2015) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR) (the "Company"), announced that on September 15, 2015, the Company received a letter from the Listing...
Egalet Corporation Launches Acura Pharmaceuticals' OXAYDO(TM)
September 09, 2015 16:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - September 09, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), today announced that Egalet Corporation (NASDAQ: EGLT) has commercially launched in the United States...
Acura Pharmaceuticals Announces 1-for-5 Reverse Stock Split
August 24, 2015 16:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - August 24, 2015) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR) (the "Company"), announced today that it will effect a 1-for-5 reverse stock split of its common stock. At a...
Acura Pharmaceuticals Announces Second Quarter 2015 Financial Results
August 03, 2015 16:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - August 03, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
Acura Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call on August 4, 2015
July 27, 2015 10:11 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, IL--(Marketwired - July 27, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company plans to...